During the investigation of the molecular mechanism underlying EMMPRIN promoting breast cancer stem-like cells, SUM102 and BT474 cells were treated with human recombinant EMMPRIN (hrEMMPRIN) and we found that STAT3 was activated (Fig. 4A). This evidence concerns the gene BSG and breast carcinoma.